U.S. Professional Services Stock News

Corvus Pharmaceuticals (CRVS) has drawn investor attention after appointing immunologist and drug development leader Dr. Andrew C. Chan to its Board of Directors. The move highlights the company’s focus on research driven decision making. See our latest analysis for Corvus Pharmaceuticals. The latest share price of US$15.46 comes after a mixed few months, with a 7.1% 30 day share price return set against a 25.3% decline over 90 days. At the same time, a year to date share price return of...

If you are wondering whether JPMorgan Chase is attractively priced or running ahead of its fundamentals, the current share level invites a closer look at what you are really paying for. At a last close of US$312.47, the stock has returned 1.4% over 7 days, 5.8% over 30 days, a negative 4.0% year to date, 26.2% over 1 year, 144.7% over 3 years and 119.9% over 5 years. This provides additional context for any assessment of value and risk. Recent coverage has focused on JPMorgan Chase as a...

Beam Therapeutics (BEAM) is back in focus after TIME named it among 2026’s 10 Most Influential Health & Life Science Companies, alongside encouraging Phase 1/2 BEACON data in sickle cell disease treatment. See our latest analysis for Beam Therapeutics. Investors appear to be responding to the TIME recognition and encouraging BEACON data, with the 7-day share price return of 13.24% and 30-day share price return of 26.75% pointing to strengthening momentum. The 1-year total shareholder return...

In April 2026, General Mills’ Old El Paso brand marked the rare overlap of Cinco de Mayo and Taco Tuesday with a limited-edition “Taco Totality Gear Box,” featuring new TABASCO Sauce flavored taco shells and themed taco-night accessories, while also expanding its TABASCO-infused Stand ‘N Stuff shells and seasoning nationwide. At the same time, General Mills is contending with weakening sales volumes, shrinking earnings and only partial progress on its greenhouse gas reduction goals,...

Recent performance and context for Loma Negra Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) has drawn investor attention after recent trading, with the share price at US$10.61 and total return figures that differ sharply between shorter and longer time frames. See our latest analysis for Loma Negra Compañía Industrial Argentina Sociedad Anónima. The recent 1 day share price return of 3.89% decline and year to date share price return of 17.62% decline suggest momentum has...

In April 2026, ADTRAN Holdings announced an expanded phase of its partnership with GLDS to deliver billing-driven, zero-touch automation across subscriber, service and device lifecycles, while also securing conditional FCC approval that exempts its SDG carrier-grade router portfolio from Covered List restrictions through October 1, 2027. Together, these developments strengthen ADTRAN’s role in automated broadband service management and provide greater regulatory clarity for service providers...

If you are wondering whether Valero Energy's current share price still makes sense, it helps to step back and look at what the recent performance and valuation numbers are really telling you. The stock recently closed at US$246.87, with returns of 4.7% over 7 days, 2.2% over 30 days, 49.3% year to date, 113.7% over 1 year, 152.6% over 3 years and 264.6% over 5 years. Recent price action has kept Valero Energy on the radar for investors who are trying to connect the share price with...

This article considers whether Applied Optoelectronics, at a recent price of US$183.51, is still offering value or whether the share price has moved ahead of underlying expectations, and explores what the current market price might be implying. The stock has seen sharp moves recently, with returns of 13.2% over 7 days, 76.6% over 30 days and 363.4% year to date, while the 1 year and 3 year returns are both very large compared to the starting point. These moves have drawn attention to how the...

Why Asbury’s latest earnings caught investors’ attention Asbury Automotive Group (ABG) drew interest after first quarter 2026 results showed revenue of US$4,113 million, slightly below a year earlier, along with higher net income and earnings per share from continuing operations. See our latest analysis for Asbury Automotive Group. Despite the latest earnings and share repurchases, Asbury’s 90 day share price return of 13.43% and year to date share price return of 13.52% leave the 1 year...

If you are wondering whether Group 1 Automotive at around US$353.67 is a bargain or fully priced, the key is to understand what the current share price implies about the company’s value. The stock has moved 3.6% over the last week and 6.9% over the last month. Year to date it shows a 9.9% decline and a 13.8% decline over the past year, set against longer term returns of 63.3% over three years and 115.7% over five years. Recent coverage of Group 1 Automotive has focused on the company’s...

Werner Enterprises stock performance snapshot Werner Enterprises (WERN) has caught investor attention after a recent share move, with the stock priced around US$35.91 and showing mixed returns across the past week, month, past 3 months and year to date. Over the past year, Werner Enterprises has delivered a total return of about 40%, while its 3 year and 5 year total returns sit in negative territory. This has prompted closer scrutiny of its current valuation and fundamentals. See our latest...

Wondering if Penumbra at around US$325.33 is offering you real value or just a rich price tag? This article walks through what the latest numbers actually say about the stock. The share price shows a 1.4% decline over the last 7 days and a 1.1% decline over the last 30 days, while returns stand at 5.1% year to date and 9.9% over the past year. Recent coverage around Penumbra has focused on its position in the medical equipment space and how investors are weighing growth potential against...

At the April 2026 AACR Annual Meeting, Nurix Therapeutics reported new preclinical and early clinical data showing progress across its targeted protein degradation oncology pipeline, including programs aimed at pan-mutant BRAF, CBL-B, and Aurora kinase A. Beyond individual drug candidates, the presentations underscored how Nurix’s induced proximity and protein degradation platforms may overcome resistance and pathway limitations that challenge traditional cancer therapies. With this context...

Artisan Partners Asset Management (NYSE:APAM) is signaling a push into acquisitions and new investment strategies in differentiated credit, private equity and real assets. Management has highlighted an active M&A pipeline, interest in both individual hires and larger deals, and continued R&D efforts to expand the firm’s platform. The company plans to pursue these opportunities while keeping significant excess capital available for potential transactions and organic growth...

Ensign Group (ENSG) just posted Q1 2026 results with revenue of US$1.4 billion, basic EPS of US$1.73 and net income of US$99.7 million, setting the tone for the new fiscal year. Over the past five quarters, revenue has moved from US$1.17 billion in Q1 2025 to US$1.39 billion in Q1 2026, while quarterly basic EPS has increased from US$1.41 to US$1.73, with trailing twelve month net income at US$363.4 million. With net profit margins over the last year near 7%, the focus now is on how...

For readers wondering whether Provident Financial Services at around US$22.38 is still offering value or if most of the opportunity is already priced in, this article walks through what the current numbers suggest. The stock has recent returns of 0.1% over 7 days, 5.2% over 30 days, 13.3% year to date, 37.6% over 1 year, 67.1% over 3 years and 13.2% over 5 years. These figures naturally raise questions about how much upside or downside might be left. Recent news flow around Provident...

In April 2026, Matson, Inc.’s Board declared a past second-quarter dividend of US$0.36 per share, payable on June 4, 2026 to shareholders of record on May 7, 2026. On the same day, Matson also expanded and extended its share repurchase authorization to 18,000,000 shares through December 31, 2029, highlighting ongoing cash returns to shareholders. We’ll now examine how Matson’s expanded share repurchase authorization could influence the company’s existing investment narrative and future...

IDEX Corporation has already reported first-quarter 2026 results, posting sales of US$886.9 million and net income of US$120 million, while continuing long-running capital returns with a buyback program that has retired 19,574,272 shares for about US$1.68 billion since 2008. The quarter highlighted strong momentum in the Health & Science Technologies segment, record orders, margin expansion, raised full-year growth and earnings guidance, and ongoing cash returns to shareholders through share...

Tompkins Financial Corporation previously reported first-quarter 2026 results with net interest income of US$71.86 million and net income of US$26.07 million, both higher than a year earlier, alongside modest net charge-offs of US$775,000. The bank also completed a relatively small share repurchase program and reaffirmed a quarterly dividend of US$0.67 per share, underscoring management’s ongoing capital return priorities. We’ll now consider how the strong year-over-year increase in net...

Workday (WDAY) shares have been in focus after the company unveiled a new Personnel Action Request Agent for U.S. federal agencies, while investors also look ahead to its upcoming fiscal 2027 first quarter earnings release. See our latest analysis for Workday. The new PAR Agent and recent client wins arrive against a mixed backdrop, with a 1 day share price return of 3.7% and a year to date share price return of a 38.3% decline, while the 1 year total shareholder return of a 48.9% decline...

Event context and recent share performance Equity LifeStyle Properties (ELS) has recently drawn investor attention after a mild share pullback, with the stock closing at $62.82 and showing small negative returns over the week, month and past 3 months. See our latest analysis for Equity LifeStyle Properties. That recent pullback sits against a quieter backdrop, with a 5.07% year to date share price return but a 1.05% decline in 1 year total shareholder return hinting that momentum has...

Essex Property Trust overview after recent performance Essex Property Trust (ESS) has drawn fresh attention after recent price moves, with the stock last closing at US$263.35 and showing mixed total returns across the past year and past 3 months. See our latest analysis for Essex Property Trust. The share price has picked up recently, with a 1 month share price return of 8.34% and a 3 month share price return of 4.56%. However, the 1 year total shareholder return of 6.45% contrasts with a 3...

Investor attention has turned back to Dollar General (DG) after its shares outperformed the broader market, with sentiment now closely tied to expectations for earnings and revenue growth in the upcoming report. See our latest analysis for Dollar General. Recent trading has been choppy, with a 90 day share price return of a 20.22% decline and a year to date share price return of a 16.36% decline, even as the 1 year total shareholder return of 29.30% hints that sentiment has improved compared...

Pharvaris recently presented data at the Consortium of Independent Immunology Clinics Spring 2026 Conference showing that combining its deucrictibant extended-release tablet for prophylaxis with immediate-release capsules for breakthrough hereditary angioedema attacks appears to have adequate safety margins across anticipated dosing scenarios. An additional post-hoc analysis of the CHAPTER-1 study suggested that using a bradykinin B2 receptor antagonist both for prophylaxis and on-demand...